2GTK
Structure-based Design of Indole Propionic Acids as Novel PPARag CO-Agonists
2GTK の概要
| エントリーDOI | 10.2210/pdb2gtk/pdb |
| 分子名称 | Peroxisome proliferator-activated receptor gamma, Decamer from Nuclear receptor coactivator 1, (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID, ... (4 entities in total) |
| 機能のキーワード | nuclear receptor, transcription regulator |
| 由来する生物種 | Homo sapiens (human) 詳細 |
| 細胞内の位置 | Nucleus: P37231 Q15788 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 32591.31 |
| 構造登録者 | Kuhn, B.,Hilpert, H.,Benz, J.,Binggeli, A.,Grether, U.,Humm, R.,Maerki, H.-P.,Meyer, M.,Mohr, P. (登録日: 2006-04-28, 公開日: 2006-09-26, 最終更新日: 2024-04-03) |
| 主引用文献 | Kuhn, B.,Hilpert, H.,Benz, J.,Binggeli, A.,Grether, U.,Humm, R.,Meyer, M.,Mohr, P. Structure-based design of indole propionic acids as novel PPARalpha/gamma co-agonists Bioorg.Med.Chem.Lett., 16:4016-4020, 2006 Cited by PubMed Abstract: In the quest for novel PPARalpha/gamma co-agonists as putative drugs for the treatment of type 2 diabetes and dyslipidemia, we have used a structure-based design approach to identify propionic acids with a 1,5-disubstituted indole scaffold as potent PPARalpha/gamma activators. Compounds 13, 24, and 28 are examples of submicromolar dual agonists with different alpha/gamma EC50 ratios that are selective against the delta-isoform. Analysis of the X-ray complex structure of PPARgamma with the indole propionic acid 13 provides a rationalization for some of the observed SAR. PubMed: 16737814DOI: 10.1016/j.bmcl.2006.05.007 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






